| Board Name | Posts By royferns2727 | Post Created |
|---|---|---|
| No results found. | ||
Recent Articles
- ProQR Therapeutics Set to Showcase Innovations in RNA Editing
- Ransomware Threats: The Rise of Agentic AI and Its Impacts
- LIS Technologies Welcomes Ryan Norton as Senior Engineer
- Actian Unveils Data Observability for Enhanced Data Quality
- Alaska Airlines Expands Global Reach with New Tokyo Service
- NeurAxis Achieves Impressive Revenue Growth in Q1 2025
- Settlement Proposed in Sea Limited Securities Litigation Case
- Assouline Launches Elegant Home Fragrance Collection
- Vaxart Outlines Reverse Stock Split for Nasdaq Compliance
- Explore the New LG OLED B5 Series: Pricing and Features
- Belite Bio's Upcoming Investor Conferences and Presentations
- Kimera Labs Makes Waves in Health Innovation with XPRIZE
- Tevogen Bio: Pioneering Cost-Effective Innovations in Biopharma
- Govee's Innovative Strip Light Skyline Kit Offers Transformative Light
- Lincoln Educational Services Showcases Robust Q1 Growth
- Anixa Biosciences Showcases Breakthrough Ovarian Cancer Research
- Aarki Unveils Encore: Revolutionizing Mobile Marketing Growth
- Collegium Pharmaceutical Announces Exciting Share Buyback Plan
- Apexon Partners with Dataiku to Drive AI Innovation Forward
- Nature's Path Unveils Brother Nature: A New Organic Movement
- IMUNON Reveals Promising Financial Progress and Updates
- NRx Pharmaceuticals to Share Key Financial Insights Soon
- Healthy Choice Wellness Corp. Reports Impressive Q1 Growth
- Lamina Partners with nCino to Transform Loan Workflows
- Bitget's Humanitarian Efforts in Myanmar After Earthquake
- PNC Bank Launches Spend Wise Credit Card to Promote Financial Wellbeing
- ZA Miner Launches Innovative Bitcoin Mining Solution
- Genpact's Leadership in ServiceNow Ecosystem Solutions
- CervoMed's Q1 Financial Update: Progress in Neurological Trials
- Pearson PLC Announces New Share Options for Management Personnel
- Quantum BioPharma Completes Key Toxicity Studies for MS Drug
- Gstar Subic Unveils First High-Efficiency N-Type Module
- Annexon, Inc. Advances Key Therapies and Reports Q1 Results
- DeFi Development Corp. Expands SOL Holdings Beyond $100 Million
- Enphase Energy Launches Innovative Balcony Solar System in Belgium
- Opus Genetics Showcases Groundbreaking Findings at Key Conferences
- Oxford Lane Capital Corp. Prepares for Q4 Earnings Call Soon
- Galectin Therapeutics Unveils NAVIGATE Study Findings at EASL 2025
- Gabelli Funds Announces Insightful Media & Entertainment Event
- CPS Technologies Set for Engagement at Upcoming Conference
- Longevity Health Holdings Implements 1-for-30 Reverse Split
- Esperion Advances in Patent Settlement, Securing NEXLETOL® Market
- Windtree Therapeutics Unveils Key Findings on Istaroxime
- ProStar and JAVAD GNSS Team Up for Innovative Mapping Solutions
- Shai Lankry Joins Purple Biotech as New CFO Driving Growth
- Strategic Moves by Neinor Homes to Monetize BTR Portfolio
- LNG Energy Group Faces Cease Trade Order Amid Filing Delay
- OSB Group's Management Shareholding Notification Explained
- Solo Brands, Inc. Reports First Quarter Financial Results
- PyroGenesis Secures $2.39 Million in Initial Loan Tranche